Now Reading
AstraZeneca to acquire Alexion in $39 billion deal

AstraZeneca to acquire Alexion in $39 billion deal

December 12, 2020

(Reuters) – AstraZeneca Plc will acquire U.S. based Alexion Pharmaceuticals in a $39 billion deal, the company said in a statement on Saturday.

Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share, the company said.

(Reporting by Aishwarya Nair in Bengaluru; Editing by Toby Chopra)

The post AstraZeneca to acquire Alexion in billion deal first appeared on One America News Network.

What's Your Reaction?
Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

© 2020 Myrtle Beach Choice. All Rights Reserved.

Scroll To Top